Mirum Pharmaceuticals is a biopharmaceutical company that develops treatments for rare and orphan diseases. Their focus is on novel therapies, including lead product candidate LIVMARLI, which is intended for use in treating various hepatic diseases. Incorporated in 2018, Mirum Pharmaceuticals is based in California.